«Jet Lag Syndrome

Below is an extended Jet Lag Syndrome patents listing. Click here to return to the Jet Lag Syndrome main in depth entry.

Patents :
US Patent No.	Title
5805267	Interactive light field for programmed non-visual stimulation and monitoring
6274604	Alteration of circadian rhythmicity with a tachykinin antagonist
6329401	Enhancement of sleep with a tachykinin antagonist
6344342	Human G protein coupled lysophosphatidic acid receptor
6372757	Phenylurea and phenylthio urea derivatives
6410529	Phenyl urea and phenyl thiourea derivatives as HFGAN72 antagonists
6525073	Prevention or treatment of insomnia with a neurokinin-1 receptor antagonist
6586478	Methods and compositions for improving sleep
6596730	Phenyl urea and phenyl thiourea derivatives
6663859	Compositions for enhancing the immune response
6664229	Methods for treatment using novel ligands of the neuropeptide receptor HFGAN72
6242572	Human G protein coupled lysophosphatidic acid receptor
6235789	Benzocycloalkene compounds, their production and use
6218429	Tricyclic compounds, their production and use
5922771	Benzocycloalkene compounds, their production and use
5923398	Interactive light field for non-visual stimulation
5932541	Method of adjusting the circadian rhythm of a mammal
5985874	Substituted morpholine derivative and its use as a therapeutic agent
6034105	Alteration of circadian rhythmicity with a tachykinin antagonist
6034239	Tricyclic compounds, their production and use
6071927	Spiro-piperidine derivatives and their use as therapeutic agents
6071928	Spiro-piperidine derivatives and their use as therapeutic agents
6160005	Medicament for circadian rhythm sleep disorder
6180657	Melatonin derivatives for use in treating desynchronization disorders
6677354	Piperdines for use as orexin receptor antagonists
6699879	Phenyl urea and phenyl thiourea derivatives as orexin receptor antagonists
7279578	Sulfonylamino-acetic acid derivatives
7297691	Treatment of sleep disorders with cholinesterase inhibitors
7317026	CNS target modulators
7326721	Doxepin analogs and methods of use thereof
7355042	Treatment of CNS disorders using CNS target modulators
7365077	Piperazine bis-amide derivatives and their use as antagonists of the orexin receptor
7365079	Azole derivatives
7393867	Substituted thienopyrrole carboxylic acid amides, pyrrolothiazole carboxylic acid amides, and related analogs as inhibitors of casein kinase I
7402672	Substituted 1H-pyrrolo[3,2-b, 3,2-c, and 2,3-c]pyridine-2-carboxamides and related analogs as inhibitors of casein kinase lepsilon
7405217	N-aroyl piperazine derivatives as orexin receptor antagonists
7192950	Benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonists
7189757	Treatment of sleep disorders using CNS target modulators
7166608	N-aroyl piperazine derivatives as orexin receptor antagonists
6703392	1,2,3,4-tetrahydroisoquinoline derivatives
6767897	Therapeutic uses of tri-, tetra-, penta-, and polypeptides
6869966	N-substituted-2-oxodihydropyridine derivatives
6943160	Morpholine derivatives as antagonists of orexin receptors
6977157	Clock gene promoter
7067519	7,8,9,10-tetrahydro-6H-azepino, 6,7,8,9-tetrahydro-pyrido and 2,3-dihydro-2H-pyrrolo[2,1-b]-quinazolinone derivatives
7078565	Benzamide derivatives as antagonists of orexin receptors
7105526	Benzimidazole derivatives
7138525	N-substituted-2-oxodihydropyridine derivatives
7148353	Imidazo[1,2-a] pyridine anxiolytics
7411069	Doxepin analogs and methods of use thereof

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.